Klinique Medical Clinic PCL
SET:KLINIQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (14), the stock would be worth ฿44.14 (67% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 8.4 | ฿26.5 |
0%
|
| 3-Year Average | 14 | ฿44.14 |
+67%
|
| 5-Year Average | 14.3 | ฿45.13 |
+70%
|
| Industry Average | 9.2 | ฿28.94 |
+9%
|
| Country Average | 8.6 | ฿27.17 |
+3%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
฿5.9B
|
/ |
Jul 2025
฿755.1m
|
= |
|
|
฿5.9B
|
/ |
Dec 2025
฿813.8m
|
= |
|
|
฿5.9B
|
/ |
Dec 2026
฿892.2m
|
= |
|
|
฿5.9B
|
/ |
Dec 2027
฿941.4m
|
= |
|
|
฿5.9B
|
/ |
Dec 2028
฿1B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| TH |
K
|
Klinique Medical Clinic PCL
SET:KLINIQ
|
5.8B THB | 8.4 | 16.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
98.3B USD | 14.1 | 55.6 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 7.8 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.9B USD | 0 | 12.2 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.4B EUR | 9.6 | 19.1 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.2B EUR | 9.1 | 23.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.6B USD | 12.3 | 22.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 12.3 | 25.6 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 5.4 | 11.2 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | -31 | -28.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 7.1 | 13.8 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 6.6 |
| Median | 8.6 |
| 70th Percentile | 11.4 |
| Max | 3 584.8 |
Other Multiples
Klinique Medical Clinic PCL
Glance View
The Klinique Medical Clinic Public Co., Ltd. engages in the provision of dermatology, aesthetics, cosmetic surgery,and wellness services. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2022-11-07. The firm is engaged in covering all skin and body problems, such as Ulthera SPT+, ThermageFLX Pro, Pico Clear Enlighten, CopperBromide, eLos Plus, eMatrix, New YAG Laser or liposuction, such as New Coolsculpting, VelaShape III, Emsculpt NEO, VASER, and BodyTite, as well as anti-aging medicine and women wellness. The firm's services include facelift, acne, acne scars, acne scars, shape up, Filler, Fat dissolving injections, laser hair removal, skin injection, Mesoface, meso, nose surgery, eye surgery, and facial surgery.
